TVI Testing
More
TVI Testing

Investing in Innovation: From Therapeutics to Transdermal Technologies

Investing in Innovation: From Therapeutics to Transdermal TechnologiesInvesting in Innovation: From Therapeutics to Transdermal TechnologiesInvesting in Innovation: From Therapeutics to Transdermal Technologies

About TVI

Our Mission

  TEIKOKU VENTURES, INC. is the corporate venture capital arm of Teikoku Pharma USA, Inc. Our mission is to invest in innovative early-mid stage companies that align with our strategic focus areas. 

Our Investment Focus

Therapeutic areas:

  We are actively seeking investment opportunities in the following core areas: Dermatology, Pain Management, Orthopedics, CNS, and Orphan Diseases. Our scope also includes the evaluation of biologic therapeutics, including antibodies. Moreover, we maintain an open approach to compelling ventures in adjacent therapeutic areas, considering all drug formulations and routes of administration. 

Topical & Transdermal:

  

Teikoku Pharma USA and Teikoku Seiyaku, pioneers in topical drug development and manufacturing, are eager to connect with innovative startups developing novel technologies in our field. We provide a unique opportunity for collaboration within the broader Teikoku group, alongside potential investment.

Our goal:

  Our goal is to drive innovation and address unmet medical needs through strategic investments that foster growth and improve patient outcomes.

Geographical Focus:

  Our initial focus is the United States and Japan.

TVI Location

Teikoku Ventures, Inc.

1718 Ringwood Avenue,1st Floor, Suite 1004 and 1005 , San Jose, CA 95131

Copyright © 2025 Teikoku Ventures, Inc - All Rights Reserved.


Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept